Antihistamines can influence immunotherapy response by enhancing T cell activation

Mass-producible specialized engineered T cells exhibit high cancer-killing efficacy, minimized complications compared to current cell-based immunotherapy for cancer treatment

Potential of demand response in reducing CO2 emissions

COVID-19 vaccine elicits weak antibody response in people taking immunosuppressant